Introduction In the previous chapter we considered depressive disorders and we now turn to bipolar disorders, another group of conditions in which depressive episodes are prominent. In bipolar disorder, however, the course is marked by at least one episode of mania or hypomania. Kraepelin (1921) brought mania and depression together as manic depressive psychosis, because he believed...

There is no general agreement about the best method of classifying depressive disorders. A number of approaches have been tried, based on the following:● presumed aetiology● symptomatic picture● course.Classification by presumed aetiologyHistorically, depressive disorders were sometimes classified into two kinds—those in which the symptoms were caused by factors within the individual, and...

  Introduction The next two chapters describe depressive disorders and bipolar disorder. These conditions are also called mood disorders because one of their main features is abnormality of mood. Nowadays the term is usually restricted to disorders in which this mood is depression or elation, but in the past some authors have included states of anxiety as well. In this book, anxiety...

A special kind of genetic test that helps determine the best antidepressant for patients with moderate-to-severe depression could generate substantive health system savings and greatly improve patient outcomes, according to new research from the University of British Columbia. The study, published today in CMAJ, shows that in B.C. alone, implementing pharmacogenomic testing could save...

Manifest Final Chapter Preview Mark your calendars for November 4th: Netflix exclusively delivers the long-awaited return of Manifest. Flight 828's passengers prepare for their final chapter's descent onto the streaming platform this autumn. Following a journey marked by network turbulence and cancellation, the series secured its conclusion and lands Part 1 of Season 4...

Executive Summary Neuroblastoma Drugs Market : Global neuroblastoma drugs market size was valued at USD 1.87 billion in 2024 and is projected to reach USD 3.74 billion by 2032, with a CAGR of 8.90% during the forecast period of 2025 to 2032.  The Neuroblastoma Drugs Market report gets familiar with the types of consumers, their views about the product, their buying intentions...

IntroductionOf all the major psychiatric syndromes, schizophrenia is perhaps the most difficult to define and describe. This partly reflects the fact that, over the past century or more, widely divergent concepts have been held in different countries and by different people. Although there is now a greater consensus, substantialuncertainties remain. Indeed, schizophrenia remains the best...

Executive Summary Sleeve Labels Market : The global sleeve labels market size was valued at USD 15.88 billion in 2024 and is expected to reach USD 24.19 billion by 2032, at a CAGR of 5.40% during the forecast period Sleeve Labels Market report is offered to the business with a complete overview of the market, covering various aspects such as product...